____________________ Alzheimer’s Disease and Dementias: Insights for Early Detection and Care Planning
• CPT code 99483: Used for a comprehensive cognitive assessment and care planning for patients with cogni- tive impairment, including Alzheimer disease and other dementias. It covers services such as evaluating cogni- tion, functional status, medication review, and the development of a care plan. Clinicians allowed to bill under this code include physicians, physician assistants, nurse practitioners, clinical nurse specialists, and certi- fied nurse midwives. This code can be used once per 180 days (about every 6 months). • CPT code 99484: Used for standardized cognitive performance testing, which includes the administration and scoring of tests to assess cognitive function The code HCPCS code G0505 was previously used for cogni- tive and functional assessment and care planning for patients with cognitive impairment, including Alzheimer disease and other dementias. It has been replaced by CPT Code 99483 [20]. Table 5 lists other diagnostic codes commonly used in the care of cognitive impairment or dementia. More information can be found on billing codes specific to cognitive impairment by the Alzheimer’s Association in their Cognitive Impairment Care Planning Toolkit found at https:// www.alz.org/media/Documents/Cognitive-Impairment-Care- Planning-Toolkit_1.pdf.
ASSESSING COGNITION Assessment Tools
Cognitive assessment tools are crucial for diagnosing and moni- toring Alzheimer disease and other dementias. They evaluate cognitive domains like memory, attention, language, and executive function. Common tools include the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and clock drawing test (CDT) [15; 16; 17; 18]. The MMSE assesses orientation, registration, attention, calcu- lation, recall, language, and simple commands, scoring out of 30 points. Scores of 24–30 are normal, 18–23 indicates mild impairment, and 0–17 suggests severe impairment. The MoCA provides a comprehensive assessment, including visuospatial abilities, naming, memory, attention, language, abstraction, and orientation, with scores less than 26 indicating impair- ment. The CDT evaluates executive function and visuospatial abilities by having patients draw a clock showing a specific time [15; 16; 17; 18]. Administering these tools requires a standardized approach for accuracy. The MMSE and MoCA involve guided tasks and scoring, while the CDT involves drawing a clock. Scores are compared with normative data, considering age, education, and cultural background [15; 16; 17; 18]. Choosing the right tool depends on the patient’s clinical presentation and the cognitive domains needing assessment. Other factors to consider include the patient’s language proficiency, cultural background, and any sensory or motor impairments that may affect their performance on the tests. Healthcare providers should also consider the psychometric properties of the tools, such as their sensitivity, specificity, and reliability, to ensure accurate and meaningful results. The MMSE is good for quick screenings, the MoCA for com- prehensive evaluations, and the CDT for executive function and visuospatial skills. Multiple tools can enhance diagnostic accuracy, with the MoCA being particularly sensitive for early impairment detection [15; 18]. COGNITIVE ASSESSMENT BILLING Billing for cognitive assessment and care planning is essential for ensuring that healthcare providers are reimbursed for the time and resources spent on these critical services. The Centers for Medicare & Medicaid Services (CMS) have established specific billing codes for cognitive assessment and care plan- ning services. These codes allow healthcare providers to bill for the time spent on comprehensive cognitive assessments and care planning for patients with cognitive impairment, including Alzheimer disease and other dementias [4]. The primary codes include [19]:
COMMONLY USED DIAGNOSTIC CODES
Code Description G31.09 Frontotemporal Dementia G31.83 Dementia with Lewy Bodies G31.84 Mild Cognitive Impairment
G30.0 Alzheimer’s Disease with Early Onset G30.1 Alzheimer’s Disease with Late Onset G30.9 Alzheimer’s Disease Unspecified F03.90 Unspecified Dementia without Behavioral Disturbance F03.91 Unspecified Dementia with Behavioral Disturbance F01.50 Vascular Dementia without Behavioral Disturbances F01.51 Vascular Dementia with Behavioral Disturbances F02.80 Dementia in Other Diseases Classified Elsewhere with Behavioral Disturbances F02.81 Dementia in Other Diseases Classified Elsewhere with Behavioral Disturbances F03.91 Unspecified Dementia with Behavioral Disturbances Source: Compiled by Author Table 5
9
Book Code: ANCCTX2027
EliteLearning.com/Nursing
Powered by FlippingBook